ID

23028

Descripción

NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Cohort Study) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Link

https://clinicaltrials.gov/ct2/show/NCT00340080

Palabras clave

Versiones (1)
  1. 20/6/17 20/6/17 -
Subido en

20 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Genetic Screening For HLA-B*5701 n Patients with HIV Day 1 NCT00340080

Inglés

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 formularios  
Day 1
Descripción

Day 1

Alias
UMLS CUI-1
C1516637
UMLS CUI-2
C0009247
Subject Identifier
Descripción

Subject Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Descripción

Visit Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
Descripción

cohort sub-study

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C0009247
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
Descripción

If Yes, record each medication on a separate line using Trade Names where possible.

Tipo de datos

text

Alias
UMLS CUI [1]
C1963724
Drug Name (Trade name preferred)
Descripción

If Yes, record each medication on a separate line using Trade Names where possible.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C1963724
Start Date
Descripción

If Yes, record each medication on a separate line using Trade Names where possible.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1963724
Stop Date
Descripción

If Yes, record each medication on a separate line using Trade Names where possible.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1963724
Ongoing Medication?
Descripción

If Yes, record each medication on a separate line using Trade Names where possible.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1963724
Vital signs: Blood pressure systolic
Descripción

Blood pressure systolic

Tipo de datos

integer

Unidades de medida
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Vital signs: Blood pressure diastolic
Descripción

Blood pressure diastolic

Tipo de datos

integer

Unidades de medida
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Vital signs: Heart rate
Descripción

Heart rate

Tipo de datos

integer

Unidades de medida
  • beats/minute
Alias
UMLS CUI [1]
C0018810
beats/minute
Vital signs: Temperature
Descripción

Temperature

Tipo de datos

float

Unidades de medida
  • °C
Alias
UMLS CUI [1]
C0005903
°C
Volver a la parte superior de la página

Similar models

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Day 1
C1516637 (UMLS CUI-1)
C0009247 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
text
C1516637 (UMLS CUI [1,1])
C0009247 (UMLS CUI [1,2])
Eligibility Question
Code List
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
CL Item
Yes (Y)
CL Item
No (N)
Item
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
text
C1963724 (UMLS CUI [1])
Eligibility Question
Code List
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name (Trade name preferred)
text
C2360065 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Eligibility Question
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Blood pressure systolic
Item
Vital signs: Blood pressure systolic
integer
C0871470 (UMLS CUI [1])
Blood pressure diastolic
Item
Vital signs: Blood pressure diastolic
integer
C0428883 (UMLS CUI [1])
Heart rate
Item
Vital signs: Heart rate
integer
C0018810 (UMLS CUI [1])
Temperature
Item
Vital signs: Temperature
float
C0005903 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial